Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 597.67% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 690.7% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
What is the target price for Third Harmonic Bio (THRD)?
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Jefferies on October 10, 2022. The analyst firm set a price target for $30.00 expecting THRD to rise to within 12 months (a possible 597.67% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Jefferies, and Third Harmonic Bio initiated their buy rating.
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 597.67% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 690.7% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 12 月 16 日 | -16.28% | 傑富瑞 | 30 美元 → 3.6 美元 | 降級 | 買入 → 持有 |
| 2022 年 10 月 10 日 | 597.67% | 傑富瑞 | → 30 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 10 月 10 日 | 690.7% | 摩根士丹利 | → 34 美元 | 啓動覆蓋開啓 | → 超重 |
| 2022 年 10 月 10 日 | — | Cowen & Co. | 啓動覆蓋開啓 | → 跑贏大盤 |
What is the target price for Third Harmonic Bio (THRD)?
三諧波生物（THRD）的目標價格是多少？
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Jefferies on October 10, 2022. The analyst firm set a price target for $30.00 expecting THRD to rise to within 12 months (a possible 597.67% upside). 3 analyst firms have reported ratings in the last year.
傑富瑞集團於2022年10月10日公佈了第三諧波生物（納斯達克股票代碼：THRD）的最新目標股價。這家分析公司將目標股價定爲30.00美元，預計THRD將在12個月內升至12個月內（可能上漲597.67％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
分析師對Third Harmonic Bio（THRD）的最新評級是多少？
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Jefferies, and Third Harmonic Bio initiated their buy rating.
Third Harmonic Bio（納斯達克股票代碼：THRD）的最新分析師評級由傑富瑞提供，Third Harmonic Bio啓動了買入評級。
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Third Harmonic Bio（THRD）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表、與Third Harmonic Bio的高管和客戶交談以及聽取財報電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Third Harmonic Bio的最後一次評級是在2022年10月10日提交的，因此您應該預計下一個評級將在2023年10月10日左右公佈。
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
分析師對三諧波生物（THRD）的評級正確嗎？
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Third Harmonic Bio（THRD）評級是最初的，目標股價爲0.00美元至30.00美元。Third Harmonic Bio（THRD）目前的交易價格爲4.30美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧